Audited by PwC

Statement of the Board of Directors and and Executive Management

The Board of Directors and Executive Management have considered and approved the Annual Report for 2008 of Novozymes A/S.

The consolidated financial statements are presented in accordance with the International Financial Reporting Standards, as adopted by the EU, and the Parent Company financial statements are presented in accordance with the Danish Financial Statements Act. In addition, the Annual Report has been prepared in accordance with the additional Danish annual report requirements for listed companies.

In our opinion, the accounting policies used are appropriate, and the Group’s internal controls relevant to preparation and presentation of an annual report are adequate. The Annual Report therefore provides a true and fair view of the Group’s and the Parent Company’s assets, liabilities and financial position at December 31, 2008 and of the results of the Group’s and the Parent Company’s operations and consolidated cash flows for the financial year 2008.

We further consider that the Management’s review in the Annual Report gives a true and fair view of the development in the Group’s activities and business, the profit for the year, and the Group’s financial position as a whole, and a description of the most significant risks and uncertainties to which the Group is subject.

We recommend that the Annual Report be approved by the Annual Shareholders’ Meeting.


Bagsvaerd, January 22, 2009

Management:



Steen Riisgaard
President & CEO

Per Falholt



Benny D. Loft

Thomas Nagy



Peder Holk Nielsen

Thomas Videbæk

 

Board of Directors:


Henrik Gürtler
Chairman

Kurt Anker Nielsen
Vice-Chairman

Paul Petter Aas

Arne Juul Hansen

Jerker Hartwall



Søren Henrik Jepsen

Ulla Morin

Walther Thygesen

Mathias Uhlén